Company Profile
History
LTL Pharma was established by Unison Capital Group in August 2016.
It began its operation by sequentially succeeding 16 ethical drug products from Astellas Pharma Inc.
In addition to manufacturing and marketing of the ethical drugs in Japan, LTL Pharma operates overseas business in alliance with the local partners.
In February 2026, Oji Holdings Corporation joined as a shareholder.
Company Profile
- Name
- LTL Pharma Co., Ltd.
- Location
- 〒160-0023
13th Floor, Nittochi Nishi-Shinjuku Building, 6-10-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan - Representative
- Tetsuo Ito, Representative Director, President
- Establishment
- August 2016
- Capital
- 3.65 billion yen
- Number of employees
- 80
- Business Details
- Manufacturing, marketing and import/export of ethical drugs
Map
Access: 3 minutes on foot from No.2 exit of Nishi-shinjuku station of Tokyo metro's Marunouchi Line